Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19

Background Considering the widespread risk of collider bias and confounding by indication in previous research, the associations between renin‐angiotensin aldosterone system (RAAS) inhibitor use and COVID‐19 remain unknown. Accordingly, this study tested the hypothesis that RAAS inhibitors influence...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Jordan Loader, Erik Lampa, Stefan Gustafsson, Thomas Cars, Johan Sundström
Format: Artykuł
Język:English
Wydane: Wiley 2021-08-01
Seria:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Hasła przedmiotowe:
angiotensin II receptor blocker
angiotensin‐converting enzyme inhibitor
COVID‐19
hypertension
SARS‐CoV‐2
Dostęp online:https://www.ahajournals.org/doi/10.1161/JAHA.120.021154

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.021154

Podobne zapisy